Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2010 1
2013 1
2014 1
2015 2
2020 1
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR Jr, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW. Mohr FW, et al. Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5. Lancet. 2013. PMID: 23439102 Clinical Trial.
BACKGROUND: We report the 5-year results of the SYNTAX trial, which compared coronary artery bypass graft surgery (CABG) with percutaneous coronary intervention (PCI) for the treatment of patients with …
BACKGROUND: We report the 5-year results of the SYNTAX trial, which compared coronary artery bypass gr
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3).
Matsumura-Nakano Y, Shiomi H, Morimoto T, Yamaji K, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; On behalf the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Matsumura-Nakano Y, et al. Am J Cardiol. 2021 Apr 15;145:25-36. doi: 10.1016/j.amjcard.2020.12.076. Epub 2021 Jan 14. Am J Cardiol. 2021. PMID: 33454340
There is a scarcity of data comparing long-term clinical outcomes between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with three-vessel coronary artery
There is a scarcity of data comparing long-term clinical outcomes between percutaneous coronary intervention (PCI) and …
Ten-Year All-Cause Mortality Following Staged Percutaneous Revascularization in Patients With Complex Coronary Artery Disease.
Kawashima H, Ono M, Hara H, de Winter RJ, Holmes DR, Thuijs DJFM, Milojevic M, Garg S, Serruys PW, Onuma Y; SYNTAX Extended Survival Investigators. Kawashima H, et al. Cardiovasc Revasc Med. 2022 May;38:124-126. doi: 10.1016/j.carrev.2021.08.027. Epub 2021 Sep 2. Cardiovasc Revasc Med. 2022. PMID: 34503909
BACKGROUND: Medical and/or economic reasons sometimes necessitate the staging of percutaneous coronary intervention (SPCI) procedures in patients with complex coronary artery disease; however, the impact of this on very long-term o …
BACKGROUND: Medical and/or economic reasons sometimes necessitate the staging of percutaneous coronary intervention (SP …
Effects of peripheral artery disease on long-term outcomes after percutaneous coronary intervention versus coronary artery bypass grafting in patients with severe coronary artery disease.
Nishikawa R, Shiomi H, Morimoto T, Yamamoto K, Sakamoto H, Tada T, Kaneda K, Nagao K, Nakatsuma K, Tazaki J, Suwa S, Inoko M, Yamazaki K, Tsuneyoshi H, Komiya T, Ando K, Minatoya K, Furukawa Y, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 investigators. Nishikawa R, et al. J Cardiol. 2023 Dec 21:S0914-5087(23)00306-4. doi: 10.1016/j.jjcc.2023.12.004. Online ahead of print. J Cardiol. 2023. PMID: 38135147
BACKGROUND: There is a scarcity of data evaluating the effect of peripheral artery disease (PAD) on long-term mortality after percutaneous coronary intervention (PCI) relative to coronary artery bypass grafting (CABG) in …
BACKGROUND: There is a scarcity of data evaluating the effect of peripheral artery disease (PAD) on long-term mortality after …
Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ; SYNTAX trial investigators. Osnabrugge RL, et al. Heart. 2015 Dec;101(24):1980-8. doi: 10.1136/heartjnl-2015-307578. Epub 2015 Nov 9. Heart. 2015. PMID: 26552756 Clinical Trial.
AIMS: Recent cost-effectiveness analyses of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) have been limited by a short time horizon or were restricted to the US healthcare perspective. ...ME …
AIMS: Recent cost-effectiveness analyses of percutaneous coronary intervention (PCI) versus coronary a
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.
Takahashi K, Serruys PW, Fuster V, Farkouh ME, Spertus JA, Cohen DJ, Park SJ, Park DW, Ahn JM, Kappetein AP, Head SJ, Thuijs DJ, Onuma Y, Kent DM, Steyerberg EW, van Klaveren D; SYNTAXES, FREEDOM, BEST, and PRECOMBAT trial investigators. Takahashi K, et al. Lancet. 2020 Oct 31;396(10260):1399-1412. doi: 10.1016/S0140-6736(20)32114-0. Epub 2020 Oct 8. Lancet. 2020. PMID: 33038944 Clinical Trial.
Patients with de-novo three-vessel and left main coronary artery disease were randomly assigned (1:1) to either the percutaneous coronary intervention (PCI) group or coronary artery bypa
Patients with de-novo three-vessel and left main coronary artery disease were random
Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
Ono M, Kawashima H, Hara H, Mancone M, Mack MJ, Holmes DR, Morice MC, Kappetein AP, Thuijs DJFM, Noack T, Mohr FW, Davierwala PM, Onuma Y, Serruys PW; SYNTAX Extended Survival Investigators. Ono M, et al. Int J Cardiol. 2021 Oct 15;341:9-12. doi: 10.1016/j.ijcard.2021.08.013. Epub 2021 Aug 8. Int J Cardiol. 2021. PMID: 34375706 Free article. Clinical Trial.
BACKGROUND: The significant interaction between major infection and 5-year mortality after percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) for complex coronary artery d
BACKGROUND: The significant interaction between major infection and 5-year mortality after percutaneous coronary
The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A, Bartolini D, Finlay MC, Qureshi AC, Flather M, Strange JW, Hall RJ. Kapur A, et al. J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32. J Cardiovasc Med (Hagerstown). 2010. PMID: 19797974
OBJECTIVES: The aim of the Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes study was to assess percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) as treatments for multivessel …
OBJECTIVES: The aim of the Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes study was to assess percutaneous
Mortality after multivessel revascularisation involving the proximal left anterior descending artery.
Ono M, Hara H, Gao C, Kawashima H, Wang R, O'Leary N, Wykrzykowska JJ, Piek JJ, Mack MJ, Holmes D, Morice MC, Head S, Kappetein AP, Noack T, Davierwala PM, Mohr FW, Garg S, Onuma Y, Serruys PW; SYNTAX Extended Survival Investigators. Ono M, et al. Heart. 2022 Oct 28;108(22):1784-1791. doi: 10.1136/heartjnl-2022-320934. Heart. 2022. PMID: 35732441 Free PMC article.
OBJECTIVE: We sought to investigate whether long-term clinical outcomes differ following percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with three-vessel disease
OBJECTIVE: We sought to investigate whether long-term clinical outcomes differ following percutaneous coronary intervention
Early and five-year results for coronary artery bypass grafting. A benchmark for percutaneous transluminal coronary angioplasty.
Daily PO. Daily PO. J Thorac Cardiovasc Surg. 1989 Jan;97(1):67-77. J Thorac Cardiovasc Surg. 1989. PMID: 2521367
Patients currently undergoing coronary artery bypass grafting will likely have worse early and late results because of the selection of patients with fewer risk factors for percutaneous transluminal coronary angioplasty. ...To obta
Patients currently undergoing coronary artery bypass grafting will likely have worse early and late results beca
11 results